The Texas Emerging Technology Fund is investing $9.2 million in three companies spun off from InCube Labs to develop treatments for iron-deficiency anemia, epilepsy, and atrial fibrillation. The companies will relocate to San Antonio from California.

"Texas continues to be a leader in jobs, innovation and technological development, thanks in part to investments through the Texas Emerging Technology Fund, which have attracted top researchers and cutting edge companies to the state," said Governor Rick Perry. "InCube's three spin-out companies have the potential to develop groundbreaking treatments for some of the most common and most challenging medical conditions we are faced with today."

Corhythm Inc. will receive $3.1 million to develop an implant that detects early onset atrial fibrillation and chronic heart failure. Fe3 Medical Inc. will receive $2.8 million to commercialize an anemia drug delivery technology. And Neurolink Inc. will receive $3.2 million to develop an implant to predict and treat epilepsy.